This attention to innovation began to pay off in the 1980s ... downs Like most pharma companies of its size, Pfizer has faced its fair share of controversy as one of the most well-known drugmakers ...

Risperdal is well-known due to the controversy ... to pay $716 million in September and an additional $1.73 billion the following February. William C. Weldon became the Chairman and CEO of J ...

Donald Trump takes biopharma on a tariff-themed rollercoaster ride; J&J kicks off the Q1 earnings season; experts express concern about the FDA’s future; Pfizer’s obesity setback could be Viking’s ...

In his 13 years as CEO at Amgen, Robert Bradway has seen many of his counterparts at other major biopharma companies come and ...

Pay for Mayo Clinic’s top leaders grew at rates between 16% and 27% in 2023. CEO Dr. Gianrico Farrugia earned $4.3 million, and overall, 33 execs were paid more than $1 million. Mayo Clinic CEO ...

The percentage increase calculations are based on the full salary figures. According to the most recent 990, covering 2023, the next two highest paid executives after Farrugia — Mayo Clinic ...

Some analysts had expressed optimism about the danuglipron program, based in part on comments by Pfizer executives. The U.S. Food and Drug Administration is finalizing plans to replace some of the ...

A key vaccine advisory committee is meeting for the first time under new U.S. Health Secretary Robert F. Kennedy Jr., a ...

WASHINGTON — Secretary of State Marco Rubio on Wednesday shuttered the State Department’s controversial Global Engagement Center, which under the Biden administration faced heavy criticism ...

Healthcare & Pharmaceuticalscategory· April 14, 2025 Pfizer ends development of weight ... Sustainabilitycategory· April 7, 2025 Viatris to pay up to $335 million to resolve opioid-related ...